Heterogeneity in verbal memory: A marker of preclinical Alzheimer's disease?

Aging, Neuropsychology, and Cognition

Volumn 13, Issue 3-4, 2006, Pages 503-515

  Wetter, Spencer ^a   Delis, Dean ^a,b   Houston, Wes ^a   Jacobson, Mark ^b   Lansing, Amy ^b   Cobell, Krystal ^a   Salmon, David ^b   Bondi, Mark ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CALIFORNIA VERBAL LEARNING TEST; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE MARKER; EDUCATION; FEMALE; GENDER; GENETIC RISK; GENOTYPE; HUMAN; LEARNING TEST; LINGUISTICS; LOGISTIC REGRESSION ANALYSIS; MALE; NEUROPSYCHOLOGY; PROSPECTIVE STUDY; RECALL; VARIANCE; VERBAL BEHAVIOR; VERBAL MEMORY; WECHSLER INTELLIGENCE SCALE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK; VERBAL LEARNING;

EID: 33746903525     PISSN: 13825585     EISSN: 17444128     Source Type: Journal    
DOI: 10.1080/138255890969492     Document Type: Article

References (32)

1. Bondi, M. W., Salmon, D. P., Galasko, D., Thomas, R. G., & Thal, L. J. (1999). Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychology & Aging, 14, 295-303.
2. Bondi, M. W., Salmon, D. P., Monsch, A. U., Galasko, D., Butters, N., Klauber, M. R., Thal, L. J., and Saitoh, T. (1995). Episodic memory changes are associated with the APOE-e4 allele in nondemented older adults. Neurology, 45, 2203-2206.
3. Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000). Patterns of brain activation in people at risk for Alzheimer's disease. The New England Journal of Medicine, 343, 450-456).
4. Brown, M. B., & Forsythe, A. B. (1974). Robust tests for equality of variances. Journal of the America Statistical Association, 69, 364-367.
5. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, G. L., & Pericak-Vance, M. A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
6. Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (2000). California Verbal Learning Test - II, Second edition. San Antonio: The Psychological Coropration.
7. Delis, D. C., & Fridlund, A. J. (2000). CVLT-II Comprehensive Scoring System and Computerized Report. San Antonio: The Psychological Corporation.
8. Delis, D. C., Massman, P. J., Butters, N., Salmon, D. P. Cermak, L. S., and Kramer, J. H. (1991). Profiles of demented and amnesic patients on the California Verbal Learning Test: Implications for the assessment of memory disorders. Psychological Assessment, 3, 19-26.
9. Elias, M., Beiser, A., Wolf, P., Au, R., White, R., & D'Agostino, R. (2000). The preclinical phase of Alzheimer disease: A 22-year prospective study of the Framingham cohort. Archives of Neurology, 57, 808-813.
10. Finton, M. J., Lucas, J. A., Rippeth, J. D., Bohac, D. L., Smith, G. E., Ivnik, R. J., Petersen, R. C., & Graff-Radford, N. R. (2003). Cognitive asymmetries associated with apolipoprotein E genotype in patients with Alzheimer's disease. Journal of the International Neuropsychological Society, 9, 751-759.
11. Giancobini, E. (2000). Cholinesterase inhibitors stabilize Alzheimer disease. Neurochemical Research, 25, 1185-1190.
12. Jacobs, D. M., Sano, M., Dooneief, G., Marder, K., Bell, K., & Stern, Y. (1995). Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology, 5, 957-962.
13. Jacobson, M. W., Delis, D. C., Bondi, M. W., & Salmon, D. P. (2002). Do neuropsychological tests detect preclinical Alzheimer's disease: Individual-test versus cognitive-discrepancy score analyses. Neuropsychology, 16, 132-139.
14. Linn, R., Wolf, P., Bachman, D., & Knoefel, J. (1995). The "preclinical phase" of probable Alzheimer's disease: A 13-year prospective study of the Framingham cohort. Archives of Neurology, 52, 485-490.
15. Mattis, S. (1973). Dementia Rating Scale: Professional manual. Odessa, FL: Psychological Assessment Resources.
16. Monsch, A., Bondi, M., Salmon, D., & Butters, N. (1995). Clinical validity of the Mattis Dementia Rating Scale in detecting dementia of the Alzheimer type: A double cross-validation and application to a community-dwelling sample. Archives of Neurology, 52, 899-904.
17. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., & Ikeda, K. (1991). Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease. Brain Research, 541, 163-166.
18. Norusis, M. J. (1997). SPSS 8.0 guide to data analysis. Upper Saddle River, NJ: Prentice Hall.
19. O'Brien, R. G. (1978). Robust techniques for testing heterogeneity of variance effects in factorial designs. Psychometrika, 43, 327-344.
20. O'Brien, R. G. (1981). A simple test for variance effects in experimental designs. Psychological Bulletin, 89, 570-574.
21. Pericak-Vance, M. A., Bebout, J. L., Gaskell, P. C., Yamaoka, L. H., Hung, W. Y., Alberts, M. J., Walker, A. P., Bartlett, R. J., Haynes, C. A., and Welsh, K. A. (1991). Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage. American Journal of Human Genetics, 48, 1034-1050.
22. Reiman, E. M., Caselli, R. J., Chen, K., Alexander, G. E., Bandy, D., & Frost, J. (2001). Declining brain activity in cognitively normal apolipoprotein E e4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proceedings of the National Academy of Sciences, 98, 3334-3339.
23. Salmon, D., & Bondi, M. (1999). Neuropsychology of Alzheimer's disease. In Terry, R., Katzman, R., Bick, K., & Sisodia, S. (Eds.), Alzheimer's disease, 2nd ed. (pp. 44-45). Lippincott, Williams, and Wilkins: Philadelphia, P.A
24. Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., Hulette, C., Crain, B., Goldbager, D., & Roses, A. D. (1993). Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43, 1467-1472.
25. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., La Rue, A., Adamson, C. F., Chang, L., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D., and Seubert, P. (1999). Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 400, 173-177.
26. Small, G. W., Mazziotta, J. C., Collins, M. T., Baxter, L. R., Phelps, M. E., Mandelkern, M. A., Kaplan, A., La Rue, A., Adamson, C. F., and Chang, L. (1995). Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for Alzheimer disease. JAMA, 273, 942-947.
27. Smith, G. E., Bohac, D. L., Waring, S. C., Kokmen, E., Tangalos, E. G., Ivnik, R. J., & Petersen, R. C. (1998). Apolipoprotein E genotype influences cognitive "phenotype" in patients with Alzheimer's disease but not in healthy control subjects. Journal of Neurology, 50, 355-362.
28. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993). Apolipoprotein-E - High avidity binding to B-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences, 90, 9649-9653.
29. Sullivan, E. V., Sagar, H. J., Gabrieli, J. D. E., Corkin, S., & Growdon, J. H. (1989). Different cognitive profiles on standard behavioral tests in Parkinson's disease and Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology, 11, 799-820.
30. Thompson, P. M., Moussai, J., Zohoori, S., Goldkorn, A., Khan, A. A., Mega, M. S., et al. (1998). Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cerebral Cortex, 8, 492-509.
31. Wechsler, D. (1981). Manual for the Wechsler Adult Intelligence Scale-revised. San Antonio, TX: Psychological Corporation.
32. Welsh, K., Butters, N., Hughes, J., Mohs, R., & Heyman, A. (1991). Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Archives of Neurology, 48, 278-281.